| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Clinical experience with anthracycline antibiotics–HPMA copolymer–human immunoglobulin conjugates
|
Rihova, Blanka
|
|
2009
|
61 |
13 |
p. 1149-1158
10 p.
|
artikel
|
| 2 |
Combination therapy: Opportunities and challenges for polymer–drug conjugates as anticancer nanomedicines
|
Greco, Francesca
|
|
2009
|
61 |
13 |
p. 1203-1213
11 p.
|
artikel
|
| 3 |
Design and development of IT-101, a cyclodextrin-containing polymer conjugate of camptothecin
|
Davis, Mark E.
|
|
2009
|
61 |
13 |
p. 1189-1192
4 p.
|
artikel
|
| 4 |
Design and development of polymer conjugates as anti-angiogenic agents
|
Segal, Ehud
|
|
2009
|
61 |
13 |
p. 1159-1176
18 p.
|
artikel
|
| 5 |
Development of HPMA copolymer–anticancer conjugates: Clinical experience and lessons learnt
|
Duncan, Ruth
|
|
2009
|
61 |
13 |
p. 1131-1148
18 p.
|
artikel
|
| 6 |
Editorial Board
|
|
|
2009
|
61 |
13 |
p. ii-
1 p.
|
artikel
|
| 7 |
Functional polymers as therapeutic agents: Concept to market place
|
Dhal, Pradeep K.
|
|
2009
|
61 |
13 |
p. 1121-1130
10 p.
|
artikel
|
| 8 |
PEG conjugates in clinical development or use as anticancer agents: An overview
|
Pasut, Gianfranco
|
|
2009
|
61 |
13 |
p. 1177-1188
12 p.
|
artikel
|
| 9 |
Polymeric carriers: Preclinical safety and the regulatory implications for design and development of polymer therapeutics
|
Gaspar, Rogério
|
|
2009
|
61 |
13 |
p. 1220-1231
12 p.
|
artikel
|
| 10 |
Polymer therapeutics: Clinical applications and challenges for development
|
Vicent, María J.
|
|
2009
|
61 |
13 |
p. 1117-1120
4 p.
|
artikel
|
| 11 |
ProLindac™ (AP5346): A review of the development of an HPMA DACH platinum Polymer Therapeutic
|
Nowotnik, David P
|
|
2009
|
61 |
13 |
p. 1214-1219
6 p.
|
artikel
|
| 12 |
XMT-1001, a novel polymeric camptothecin pro-drug in clinical development for patients with advanced cancer
|
Yurkovetskiy, Alexander V.
|
|
2009
|
61 |
13 |
p. 1193-1202
10 p.
|
artikel
|
Tijdschrift beschrijving